Acromegaly clinical trials at UCLA
2 in progress, 0 open to eligible people
Showing trials for
Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
Sorry, in progress, not accepting new patients
A phase 2, open label, long-term extension study designed to evaluate the safety and efficacy of paltusotine (formerly CRN00808; an oral selective nonpeptide somatostatin receptor type 2 biased agonist) in subjects with acromegaly.
Los Angeles, California and other locations
Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Sorry, not accepting new patients
The present study is planned as an expanded treatment protocol to provide acromegalic patients for whom medical therapy is appropriate access to pasireotide LAR while regulatory approval for pasireotide is sought.
Los Angeles, California and other locations